Contraceptive Use Declines After Breast Cancer Diagnosis

For women who do not wish to become pregnant, contraceptive use after breast cancer diagnosis and treatment should be a priority, especially given restrictive access to abortions in many states.

Related Keywords

Italy ,New Haven ,Connecticut ,United States ,France ,French ,Maryam Lustberg ,Roev Wade ,Eli Lilly ,Matteo Lambertini ,Gilead Sciences ,Yale Cancer Center ,Novartis ,Supreme Court ,Pfizer ,University Of Genova ,Astrazeneca ,Us Supreme Court ,National Research Agency Of France ,National Research Agency ,Merck Sharp ,Breast Cancer ,Alignant Breast Neoplasm ,Cancer ,Alignant Neoplasia ,Arcinoma ,Pregnancy ,Chemotherapy ,Contraception ,Birth Control ,Ontraceptive Management ,Anagement Contraception ,Endocrine Therapy ,Hormone Therapy ,Tamoxifen ,Elective Estrogen Receptor Modulator Serm ,Cancer Survivor ,Abortion ,Regnancy Termination ,Hormonal Contraception ,Hormonal Contraceptive ,Medical Abortion ,Hemical Ab ,